Incannex Healthcare Inc. Indemnification AgreementIndemnification Agreement • November 29th, 2023 • Incannex Healthcare LTD • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of , and is between Incannex Healthcare Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
DEPOSIT AGREEMENT by and among Incannex Healthcare Limited as Issuer, DEUTSCHE BANK TRUST COMPANY AMERICAS as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ISSUED HEREUNDER...Deposit Agreement • January 25th, 2022 • Incannex Healthcare LTD • Pharmaceutical preparations • New York
DEPOSIT AGREEMENT, dated as of , 2022, by and among (i) Incannex Healthcare Limited, a company incorporated in the Commonwealth of Australia, with its principal executive office at Suite 15, Level 12, 401 Docklands Drive, Docklands 3008, Victoria, Australia (together with its successors, the “Company”), (ii) Deutsche Bank Trust Company Americas, an indirect wholly owned subsidiary of Deutsche Bank A.G., acting in its capacity as depositary, with its principal office at 60 Wall Street, New York, NY 10005, United States of America (the “Depositary”, which term shall include any successor depositary hereunder) and (iii) all Holders and Beneficial Owners of American Depositary Shares evidenced by American Depositary Receipts issued hereunder (all such capitalized terms as hereinafter defined).
INCANNEX HEALTHCARE LIMITED UNDERWRITING AGREEMENT [●] American Depositary Shares representing [●] Ordinary SharesUnderwriting Agreement • November 23rd, 2021 • Incannex Healthcare LTD • Pharmaceutical preparations • New York
The ADSs are to be issued pursuant to a deposit agreement (the “Deposit Agreement”), dated as of [•], 2021, among the Company, Deutsche Bank Trust Company Americas, as depositary (the “Depositary”), and holders from time to time of the American Depositary Receipts (“ADRs”) issued by the Depositary and evidencing the ADSs. The ADSs will initially represent the right to receive the Ordinary Shares deposited pursuant to the Deposit Agreement.
Research Services AgreementIncannex Healthcare LTD • January 25th, 2022 • Pharmaceutical preparations • Victoria
Monash Monash University (ABN 12 377 614 012), a body corporate constituted in accordance with the Monash University Act 2009 (Vic) of Wellington Road, Clayton, Victoria, Australia 3800
CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT WAS OMITTED BY MEANS OF MARKING SUCH INFORMATION WITH BRACKETS (“[***]”) BECAUSE THE IDENTIFIED CONFIDENTIAL INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR...Incannex Healthcare LTD • January 25th, 2022 • Pharmaceutical preparations
Name of Institution: Alfred Health a body corporate established under the Health Services Act 1988 (Vic) of Commercial Road, Melbourne, 3004 or Alfred Health
Master Service Agreement Contract DetailsMaster Service Agreement • January 25th, 2022 • Incannex Healthcare LTD • Pharmaceutical preparations • South Australia
CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT WAS OMITTED BY MEANS OF MARKING SUCH INFORMATION WITH BRACKETS (“[***]”) BECAUSE THE IDENTIFIED CONFIDENTIAL INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR...Entire Agreement • January 25th, 2022 • Incannex Healthcare LTD • Pharmaceutical preparations
Name of Institution: Alfred Health a body corporate established under the Health Services Act 1988 (Vic) of Commercial Road, Melbourne, 3004 or Alfred Health
Services AgreementServices Agreement • January 25th, 2022 • Incannex Healthcare LTD • Pharmaceutical preparations
This Agreement is made between lncannex Healthcare Limited ACN 096 635 246 of Level 39, Rialto South Tower, 525 Collins Street, Melbourne, Victoria 3000 (IHL or us) and Madhukar (Madhu) Bhalla of 4 Delgado Parade, lluka, WA 6028 (you).
CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT WAS OMITTED BY MEANS OF MARKING SUCH INFORMATION WITH BRACKETS (“[***]”) BECAUSE THE IDENTIFIED CONFIDENTIAL INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR...Incannex Healthcare LTD • January 25th, 2022 • Pharmaceutical preparations
Study Name: Dose finding crossover trial investigating the effect of dronabinol combined with acetazolamide on Apnoea Hypopnea Index (AHI) in adults with obstructive sleep apnoea (OSA)
MASTER CONSULTANCY AGREEMENTMaster Consultancy Agreement • January 25th, 2022 • Incannex Healthcare LTD • Pharmaceutical preparations • Queensland
Research Services AgreementIncannex Healthcare LTD • January 25th, 2022 • Pharmaceutical preparations • Victoria
Monash Monash University (ABN 12 377 614 012), a body corporate constituted in accordance with the Monash University Act 2009 (Vic) of Wellington Road, Clayton, Victoria, Australia 3800
Research Services AgreementIncannex Healthcare LTD • September 28th, 2021 • Pharmaceutical preparations • Victoria
Monash Monash University (ABN 12 377 614 012), a body corporate constituted in accordance with the Monash University Act 2009 (Vic) of Wellington Road, Clayton, Victoria, Australia 3800
Share Sale and Purchase Agreement betweenSale and Purchase Agreement • October 28th, 2022 • Incannex Healthcare LTD • Pharmaceutical preparations • Victoria
B The Sellers have agreed to sell all legal and beneficial interests in the Sale Shares to the Buyer and the Buyer has agreed to buy all legal and beneficial interests in the Sale Shares from the Sellers on the basis set out in this Agreement.
Deed of Amendment and RestatementIncannex Healthcare LTD • November 29th, 2023 • Pharmaceutical preparations • Victoria
B On or around the time US HoldCo entered into the SID, US HoldCo also entered into a share scheme deed poll (in the form set out in schedule 4 of the SID) (SSDP) and an option scheme deed poll (in the form set out in schedule 6 of the SID) (OSDP and collectively with the SSDP, the DPs).
